Invicta Diagnostic Stock Price Analysis and Quick Research Report. Is Invicta Diagnostic an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Invicta Diagnostic. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Invicta Diagnostic has a PE ratio of 22.7753727753728 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Invicta Diagnostic has ROA of 36.6018% which is a good sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Invicta Diagnostic has a Current ratio of 2.3331.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Invicta Diagnostic has a ROE of 51.4088%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Invicta Diagnostic has a Debt to Equity ratio of 0.1454 which means that the company has low proportion of debt in its capital.

• Sales growth: Invicta Diagnostic has reported revenue growth of 68.0181% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Invicta Diagnostic for the current financial year is 38.1408956251306%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Invicta Diagnostic is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Invicta Diagnostic is Rs 4.158. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Invicta Diagnostic in Ticker for free. Also, one can get the intrinsic value of Invicta Diagnostic by using Valuation Calculators, which are available with a Finology ONE subscription. 

Invicta Diagnostic FAQs

Q1. What is Invicta Diagnostic share price today?
Ans: The current share price of Invicta Diagnostic is Rs 94.7.

Q2. What is the market capitalisation of Invicta Diagnostic?
Ans: Invicta Diagnostic has a market capitalisation of Rs 119.05658431 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Invicta Diagnostic?
Ans: The PE ratio of Invicta Diagnostic is 22.7753727753728 and the P/B ratio of Invicta Diagnostic is 2.85151639245538, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Invicta Diagnostic share?
Ans: The 52-week high share price of Invicta Diagnostic is Rs 105, and the 52-week low share price of Invicta Diagnostic is Rs 87.35.

Q5. Does Invicta Diagnostic pay dividends?
Ans: Currently, Invicta Diagnostic does not pay dividends. Dividend yield of Invicta Diagnostic is around 0%.

Q6. What are the face value and book value of Invicta Diagnostic shares?
Ans: The face value of Invicta Diagnostic shares is Rs 10, while the book value per share of Invicta Diagnostic is around Rs 33.2104. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Invicta Diagnostic?
Ans: Invicta Diagnostic has a total debt of Rs 1.8591 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Invicta Diagnostic?
Ans: The ROE of Invicta Diagnostic is 51.4088% and ROCE of Invicta Diagnostic is 55.6484%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Invicta Diagnostic a good buy for the long term?
Ans: The Invicta Diagnostic long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Invicta Diagnostic undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Invicta Diagnostic appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Invicta Diagnostic’s financials?
Ans: You can review Invicta Diagnostic’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.